Evaluation of Serum Soluble Suppression of Tumorigenicity 2 (sST-2) in Ischemic Heart Disease
Fouda, M., Ibraheem, N., Rashid, H., Abdel Gwad, I., Abd El-Ghafar, A. (2025). Evaluation of Serum Soluble Suppression of Tumorigenicity 2 (sST-2) in Ischemic Heart Disease. EKB Journal Management System, 42(9), 62-71. doi: 10.21608/bmfj.2025.344138.2285
Mona Eltoukhy Fouda; Nancy Ibraheem; Hesham Khalid Rashid; Iman Ramadan Abdel Gwad; Amira Osama Abd El-Ghafar. "Evaluation of Serum Soluble Suppression of Tumorigenicity 2 (sST-2) in Ischemic Heart Disease". EKB Journal Management System, 42, 9, 2025, 62-71. doi: 10.21608/bmfj.2025.344138.2285
Fouda, M., Ibraheem, N., Rashid, H., Abdel Gwad, I., Abd El-Ghafar, A. (2025). 'Evaluation of Serum Soluble Suppression of Tumorigenicity 2 (sST-2) in Ischemic Heart Disease', EKB Journal Management System, 42(9), pp. 62-71. doi: 10.21608/bmfj.2025.344138.2285
Fouda, M., Ibraheem, N., Rashid, H., Abdel Gwad, I., Abd El-Ghafar, A. Evaluation of Serum Soluble Suppression of Tumorigenicity 2 (sST-2) in Ischemic Heart Disease. EKB Journal Management System, 2025; 42(9): 62-71. doi: 10.21608/bmfj.2025.344138.2285